SFX by Ex Libris Inc.

Title:	Equilibrative nucleoside transporter 3 deficiency perturbs lysosome function and macrophage homeostasis
Source:	Science [0036-8075] Hsu, C L yr:2011

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Kaetzel, M. "Fluorescently-labeled calmodoulin localizes specific sites on mitochondria." Annals of the New York Academy of Sciences (1980): 395-396.
description	2.	Jun, Rajgopal H. "Human equilibrative nucleoside transporter-3 (hENT3) spectrum disorder mutations impair nucleoside transport, protein localization, and stability." Journal of biological chemistry 285.36 (2010): 28343-52.
description	3.	Govindarajan,, Rajgopal, Jashvant D. "Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3." American journal of physiology: Gastrointestinal and liver physiology 59.4 (2009): -22.
description	4.	Barnes, K. "Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH." Circulation research 99.5 (2006): 510-9.
description	5.	Priya, T.P. P. "H syndrome: novel and recurrent mutations in SLC29A3." British journal of dermatology 162.5 (2010): 1132-4.
description	6.	Mackey JR, C. "Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations." Blood 105.2 (2005): 767-74.
description	7.	Schellens, Jan H M H. "New insights into the pharmacology and cytotoxicity of gemcitabine and 2',2'-difluorodeoxyuridine." Molecular cancer therapeutics 7.8 (2008): 2415-25.
description	8.	Cabantchik, Z I I. "Functional characterization of anion transport system isolated from human erythrocyte membranes." The Journal of biological chemistry 252.7 (1977): 2419-27.
description	9.	Drain, P. "Micronutrients in HIV-positive persons receiving highly active antiretroviral therapy." The American journal of clinical nutrition 85.2 (2007): 333-45.
description	10.	Sai, Y. "Characterization of the Mechanism of Zidovudine Uptake by Rat Conditionally Immortalized Syncytiotrophoblast Cell Line TR-TBT." Pharmaceutical Research 25.7 (2008): 1647-1653.
description	11.	Unadkat, J. "Mitochondrial expression of the human equilibrative nucleoside transporter 1 (hENT1) results in enhanced mitochondrial toxicity of antiviral drugs." The Journal of biological chemistry 279.6 (2004): 4490-4497.
description	12.	El Khateeb, Ekramy A. "The H syndrome." Pediatric dermatology 27.1 (2010): 65-8.
description	13.	Spiegel, R. "Expanding the clinical spectrum of SLC29A3 gene defects." European journal of medical genetics 53.5 (2010): 309-13.
description	14.	Friis, H. "Micronutrients and HIV infection: A review." European journal of clinical nutrition 52.3 (1998): 157-163.
description	15.	Hong, L. "Tissue distribution of concentrative and equilibrative nucleoside transporters in male and female rats and mice." Drug metabolism and disposition 32.12 (2004): 1455-61.
description	16.	Austin, J., J. "A community randomized controlled clinical trial of mixed carotenoids and micronutrient supplementation of patients with acquired immunodeficiency syndrome." European journal of clinical nutrition 60.11 (2006): 1266-1276.
description	17.	Antelman, G. "Depressive symptoms increase risk of HIV disease progression and mortality among women in Tanzania." Journal of acquired immune deficiency syndromes 44.4 (2007): 470-7.
description	18.	Young, James D D. "The equilibrative nucleoside transporter family, SLC29." Pflügers Archiv 447.5 (2004): 735-743.
description	19.	Jiamton, S. "A randomized trial of the impact of multiple micronutrient supplementation on mortality among HIV-infected individuals living in Bangkok." AIDS 17.17 (2003): 2461-9.
description	20.	Wang, L. "In vivo biodistribution, pharmacokinetic parameters, and brain uptake of 5-halo-y-methoxy(or ethoxy)-5,6-dihydro-3'-azido-3'-deoxythymidine diastereomers as potential prodrugs of 3'-azido-3'-deoxythymidine." Journal of medicinal chemistry (1996): 826-33.